Nano-Based 3D Printed Scaffold for Bone Tissue Engineering
Shi X., Liu K., Li W., Zhao R., Wang W.
Narrative Review, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Bioengineering (Basel) (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42194326
- PMCID
- PMC13203539
- DOI
- 10.3390/bioengineering13050569
Abstract (original English)
3D bioprinting technology has made great strides in the field of bone tissue engineering. It has been able to create personalized biological structures on a macroscopic scale. In terms of microstructure bionics, 3D printing technology has also made some progress in recent years. The use of nanotechnology and drug delivery technology has provided a microenvironment that is more compatible with cell growth. Finally, it is possible to bridge the gap between engineered organizational structures and natural tissues. In this work, we summarize the widely used 3D bioprinting methods and the preparation of bioinks. Next, the classification of bone tissue engineering scaffold materials and nanomaterials for loading is briefly introduced. Then the technical shortcomings of current nanotechnology-based 3D bioprinting are described, along with the corresponding improvements. Finally, we summarize the prospects of nano-based 3D bioprinting technology in bone tissue engineering.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.